1-tert-Butyl 4-ethyl 4-ethylpiperidine-1,4-dicarboxylate, 95.0%, 250mg

(R)-2-(2-Hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)isoindoline-1,3-dione, 95.0%, 25g

N-Boc-2-Piperidone, 95.0%, 100g

(S)-3-(6-Methoxy-pyrimidin-4-ylamino)-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 250mg

3-Iodoquinoline, 95.0%, 250mg

3-Methyl-isothiazole-4-sulfonic acid, 95.0%, 500mg

Boc-N-Me-D-Leu-OH, 95.0%, 25g

3-{4-[(2,5-Dimethoxyphenyl)sulfonyl]piperazin-1-yl}-3-oxo-propionic acid hydrochloride, 1g

Incubadora Heratherm Protocol series Protocolo general con convección natural, 75 l, IGS60, 1 pieza

3,4-Dihydro-8-methoxynaphthalen-1(2H)-one, 95.0%, 100mg

3,9-Bis(octadecyloxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane, 98% Carbon 64.8-69.5 %, 25g

4,4,5,5-Tetramethyl-2-(3-(trifluoromethyl)benzyl)-1,3,2-dioxaborolane, 95.0%, 1g

1,4,5,8-Tetrachloroanthraquinone>95.0%(GC)5g